# Maxcyte, Inc.: Form 8-K, filed Jun 16, 2026

- Company: [Maxcyte, Inc.](/companies/mxct.md) (CIK 1287098)
- Form: 8-K
- Filed: 2026-06-16
- Accepted by EDGAR: Jun 16, 2026, 16:21 ET
- Period: 2026-06-10
- Accession: 0001104659-26-074594
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1287098/000110465926074594/mxct-20260610x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1287098/000110465926074594/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1287098/000110465926074594/mxct-20260610x8k.htm

Filed Jun 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-074594. Last ingested by Listed: Nov 11, 2026, 01:53 ET. No prices; not investment advice.
